About Accuri Cytometers
Accuri Cytometers is a company based in Ann Arbor (United States) founded in 2004 was acquired by Becton Dickinson in February 2011. Accuri Cytometers has raised $30.91 million across 7 funding rounds from investors including Credit Suisse, BD and Flagship Pioneering. Accuri Cytometers operates in a competitive market with competitors including Cytek Biosciences, ACEA Biosciences, Bioaffinity technologies, NanoFCM and Orflo, among others.
- Headquarter Ann Arbor, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$30.91 M (USD)
in 7 rounds
-
Latest Funding Round
$6 M (USD), Series E
Jul 12, 2010
-
Investors
Credit Suisse
& 6 more
-
Employee Count
Not available
-
Acquired by
Becton Dickinson
(Feb 07, 2011)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Accuri Cytometers
Accuri Cytometers has successfully raised a total of $30.91M across 7 strategic funding rounds. The most recent funding activity was a Series E round of $6 million completed in July 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Accuri Cytometers
Accuri Cytometers has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Credit Suisse, BD and Flagship Pioneering.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare venture capital investments are made by Arboretum Ventures.
|
Locked | Locked | Locked | |
|
Private equity investments are directed toward US companies.
|
Locked | Locked | Locked | |
|
Life sciences-focused venture capital firm
|
Locked | Locked | Locked |
Investor details for Accuri Cytometers
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Accuri Cytometers
Investment portfolio details for Accuri Cytometers
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Accuri Cytometers
Detailed financials for Accuri Cytometers
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Accuri Cytometers Comparisons
Peer comparison for Accuri Cytometers
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Accuri Cytometers
Accuri Cytometers operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cytek Biosciences, ACEA Biosciences, Bioaffinity technologies, NanoFCM and Orflo, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Advanced flow cytometry systems are manufactured for research applications.
|
|
| Locked | Locked | Locked |
Instruments for life science research are developed and marketed.
|
|
| Locked | Locked | Locked |
IVD platforms are developed to detect and target cancer cells.
|
|
| Locked | Locked | Locked |
Offers advanced tools for nanoparticle analysis in biotechnology and healthcare.
|
|
| Locked | Locked | Locked |
Instrumentation for cell and protein analysis is developed and marketed.
|
Detailed competitors of Accuri Cytometers
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Accuri Cytometers
Complete news archive for Accuri Cytometers
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Accuri Cytometers
Accuri Cytometers was founded in 2004 and raised its 1st funding round 1 year after it was founded.
Accuri Cytometers is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.
Accuri Cytometers is a funded company, having raised a total of $30.91M across 7 funding rounds to date.
Accuri Cytometers developed Accuri C6 which is used in flow cytometry. Its is a compact and portable device to be used by novice and experienced researchers. The system features an software interface, software templates, and reagent kits that guide users new to flow cytometry through workflows for popular applications. Used in Immunophenotyping, Cell finction analysis, gene expression, non-mammalian studies and DNACell cycle analysis.
Accuri Cytometers's top competitors include Cytek Biosciences, Bioaffinity technologies and ACEA Biosciences.
Accuri Cytometers has 7 investors. Key investors include Credit Suisse, BD, Flagship Pioneering, Arboretum Ventures, and InvestMichigan!.